Clinical trials
Neuroma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 6 |
| Recruiting | 6 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Northwestern University | 4 |
| Ukrainian Society of Regional Anesthesia and Pain Therapy | 4 |
| Axogen Corporation | 2 |
| Danish Pain Research Center | 2 |
| Leiden University Medical Center | 2 |
| Norwegian University of Science and Technology | 2 |
| Polyganics BV | 2 |
| Washington University School of Medicine | 2 |
| Adichunchanagiri Institute of Medical Sciences, B G Nagara | 1 |
| Ain Shams University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroma | 46 |
| Pain | 7 |
| Neuralgia | 6 |
| Phantom Limb | 5 |
| Carpal Tunnel Syndrome | 4 |
| Chronic Pain | 4 |
| Peripheral Nerve Injuries | 4 |
| Cubital Tunnel Syndrome | 3 |
| Agnosia | 2 |
| Median Neuropathy | 2 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.